Class 4 Medicines Defect Information, Sevredol 10 mg and 20mg tablets, (PL 16950/0063, PL 16950/0064), EL (21)A/17
Some recent batches have not included recently approved safety-related variations to the PIL. There is no risk to product quality as a result of this issue, therefore the affected batches are not being recalled but where possible an updated PIL should be provided.
Source:
Medicines and Healthcare products Regulatory Agency
SPS commentary:
Link to updated PIL: